Hoʻomaka: Koʻikoʻi o nā ʻiole Sprague Dawley i ka noiʻi Ua lilo nā ʻiole Sprague Dawley i mea nui o ka noiʻi ʻepekema ma muli o ko lākou ʻano kūʻokoʻa a me ka versatility i nā ʻano expe.
Introduction He mea koʻikoʻi nā cell T o ka ʻōnaehana pale, e pāʻani ana i kahi kuleana koʻikoʻi i ka ʻike ʻana a me ka hakakā ʻana i nā pathogens. ʻO ke kaʻina hana o ka T cell activation he mea paʻakikī, multi-step mechanis
ʻO ka hoʻokaʻawale ʻana o Peripheral Blood Mononuclear Cells (PBMC) he hana koʻikoʻi i ka noiʻi biomedical a me nā noi lapaʻau. Loaʻa i kēia mau pūnaewele nā lymphocytes (e laʻa, T cell, B cell, NK cell) a
ʻO IPHASE, ma ke ʻano he alakaʻi i nā reagents olaola no ka noiʻi in vitro o nā lāʻau lapaʻau hou, hoʻomau i ka hoʻolauna ʻana i nā reagents noiʻi kiʻekiʻe-hope ma nā ʻano āpau a me nā ʻano e pili ana i nā makahiki o ka noiʻi a me ka ʻike hoʻomohala.
Ma ke kahua ākea o ka lāʻau lapaʻau a me ka ʻike ʻana i ka lāʻau, ua hoʻokumu ʻo IPHASE i kahi pūʻulu o nā kit biomicrosomes kiʻekiʻe-performance, me ka kit microsomes ate, kit microsomes intestinal a me nā micros intestinal.
ʻO Antibody-Drug Conjugate (ADC) kahi ʻano hou o ka lāʻau biotechnology e hui pū ana i nā pūhui therapeutic mole liʻiliʻi i ka huli ʻana i nā antibodies / ʻāpana antibody e nā loulou.
Hiki i kēia mea hana ke hoʻomau i ka hoʻomaikaʻi ʻana a me ka hoʻomaikaʻi ʻana i nā huahana a me ka lawelawe, ua like ia me nā lula o ka hoʻokūkū mākeke, kahi hui hoʻokūkū.